| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Avita Medical, Inc. (RCEL) has 8 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. RCEL is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 520.0K | $2.17M | - | |
| Dir | 86.8K | $362.7K | - | |
| Dir | 46.9K | $196.2K | - | |
| Dir | 39.8K | $166.5K | - | |
| CFO | 31.7K | $132.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2025 | McNamara Robert | Director | Buy | 10,000 | $4.50 | $45,000.00 | +13.0% | -10.7% | - | |
| Aug 26, 2025 | O'Toole David D47 | CFO | Buy | 2,000 | $4.52 | $9,040.00 | +6.7% | -17.8% | - | |
| Aug 19, 2025 | McNamara Robert | Director | Buy | 10,000 | $5.00 | $50,000.00 | +15.0% | -20.7% | - | |
| Aug 12, 2025 | O'Toole David D47 | CFO | Buy | 2,000 | $4.81 | $9,620.00 | +7.2% | -28.1% | - | |
| Mar 6, 2025 | McNamara Robert | Director | Buy | 11,000 | $8.30 | $91,300.00 | +24.0% | -28.3% | -42.3% | |
| Feb 20, 2025 | O'Toole David D47 | CFO | Buy | 1,000 | $9.90 | $9,900.00 | +4.0% | -34.5% | -51.9% | |
| Feb 20, 2025 | McNamara Robert | Director | Buy | 10,000 | $10.09 | $100,900.00 | +28.0% | -34.5% | -51.9% | |
| Feb 19, 2025 | O'Toole David D47 | CFO | Buy | 1,000 | $10.25 | $10,250.00 | +4.2% | -34.4% | -57.1% | |
| Dec 9, 2024 | Crowe Suzanne | Director | Buy | 486 | $13.15 | $6,390.90 | +1.3% | -39.3% | -74.2% | |
| Dec 5, 2024 | O'Toole David D47 | CFO | Buy | 975 | $12.46 | $12,151.75 | +2.1% | -31.5% | -71.9% |